Real-world data of dacomitinib as first-line treatment for patients with EGFR-mutant non-small-cell lung cancer by Ji Eun Shin, Hyun Ae Jung, Sehhoon Park, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn, Byoung Yong Shim

Get full text

Quantitative CT variables enabling response prediction in neoadjuvant therapy with EGFR-TKIs: are they different from those in neoadjuvant concurrent chemoradiotherapy? by Yousun Chong, Jae-Hun Kim, Ho Yun Lee, Yong Chan Ahn, Kyung Soo Lee, Myung-Ju Ahn, Jhingook Kim, Young Mog Shim, Joungho Han, Yoon-La Choi

Get full text

Clinical utility of circulating tumor DNA profiling in detecting targetable fusions in non-small cell lung cancer by Young-gon Kim, Boram Lee, Changhee Ha, Cheonghwa Lee, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Myung-Ju Ahn, Yoon-La Choi, Sehhoon Park, Jong-Won Kim

Get full text

Novel cancer‐associated secretory cells and IL‐1β+ macrophages as key players in early lung adenocarcinoma progression in female never‐smokers by Junsu Choe, Jinyeong Lim, Noeul Kang, Eun Seop Seo, Mina Hwang, Kyung Yeon Han, Se‐Hoon Lee, Myung‐Ju Ahn, Yoon‐La Choi, Hong Kwan Kim, Woong‐Yang Park, Sang‐Won Um

Get full text

Unveiling the influence of tumor and immune signatures on immune checkpoint therapy in advanced lung cancer by Nayoung Kim, Sehhoon Park, Areum Jo, Hye Hyeon Eum, Hong Kwan Kim, Kyungjong Lee, Jong Ho Cho, Bo Mi Ku, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Jung-Il Lee, Jung Won Choi, Dasom Jeong, Minsu Na, Huiram Kang, Jeong Yeon Kim, Jung Kyoon Choi, Hae-Ock Lee, Myung-Ju Ahn

Get full text